共 298 条
[11]
Chalmers J(2017)The sodium–glucose co-transporter 2 inhibitor, empagliflozin, protects against diabetic cardiomyopathy by inhibition of the endoplasmic reticulum stress pathway Cell Physiol Biochem 41 2503-2512
[12]
Pillai A(1995)Mitochondrial membrane potential monitored by JC-1 dye Methods Enzymol 260 406-417
[13]
Aksnes TA(2017)Oxidative stress and inflammation as central mediators of atrial fibrillation in obesity and diabetes Cardiovasc Diabetol 16 120-373
[14]
Schmieder RE(2015)Atrial fibrillation in patients with diabetes: molecular mechanisms and therapeutic perspectives Cardiovasc Diagn Ther 5 364-222
[15]
Kjeldsen SE(2015)Probucol prevents atrial remodeling by inhibiting oxidative stress and TNF-alpha/NF-kappaB/TGF-beta signal transduction pathway in alloxan-induced diabetic rabbits J Cardiovasc Electrophysiol 26 211-819
[16]
Ghani S(2016)NADPH oxidase inhibitor apocynin prevents atrial remodeling in alloxan-induced diabetic rabbits Int J Cardiol 221 812-564
[17]
Hua TA(2008)The characterization of high-fat diet and multiple low-dose streptozotocin induced type 2 diabetes rat model Exp Diabetes Res 2008 9-1898
[18]
Julius S(2014)Myocardial contractile dysfunction is associated with impaired mitochondrial function and dynamics in type 2 diabetic but not in obese patients Circulation 130 554-246
[19]
Zinman B(2009)Substrate-specific derangements in mitochondrial metabolism and redox balance in the atrium of the type 2 diabetic human heart J Am Coll Cardiol 54 1891-306
[20]
Wanner C(2017)Empagliflozin improves left ventricular diastolic dysfunction in a genetic model of type 2 diabetes Cardiovasc Drugs Ther 31 233-210